Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: the role of overlap with arrhythmogenic cardiomyopathy

17 May 2025 (08:00 - 12:45)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Alberto Aimo

Sant'Anna School of Advanced Studies, Pisa (Italy)

4 More presentations in this session

Presentation thumbnail

Towards a prognostically meaningful definition of non-dilated left ventricular cardiomyopathy

Doctor A. Aimo (Pisa, IT)

Abstract Slides Video

Presentation thumbnail

Prevalence and prognostic impact of aortic stenosis in wild-type transthyretin cardiac amyloidosis

Mr H. Malerbi (Toulouse, FR)

Abstract Slides Video

Presentation thumbnail

Relation of reduced left ventricular global longitudinal strain with exercise pulmonary hypertension and clinical implication in rheumatic mitral stenosis

Doctor S. Lee (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Predictors of right ventricular dysfunction in patients with surgical repair of Tetralogy of Fallot - significance of biomarkers

Assistant Professor E. Begic (Sarajevo, BA)

Abstract Slides Video

Access the full session

Session thumbnail

Diagnosis and prognosis in cardiomyopathies and valvular disease

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025

You may be interested in

Congress Presentation

Overlap in scarring phenotypes between non-dilated left ventricular cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: Implications for prognostic stratification

Congress Presentation

Towards a prognostically meaningful definition of non-dilated left ventricular cardiomyopathy

Congress Presentation

Prevalence of atrial and ventricular arrhythmias in patients with titin truncating variants across the ventricular morphofunctional phenotypic spectrum

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources